Therapeutic Innovation & Regulatory Science

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Therapeutic Innovation & Regulatory Science is a journal published by Springer Science+Business Media in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,590 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
2168-4790 · 2168-4804
Country
United States
Access
Not open access / not declared
Declared publication charge
3,590 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2018-01-01
  • PUBMED · 2015-03-01
Indexing
MEDLINE · PUBMED
APC
3,590 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
160 days received→accepted — computed from PubMed (n=97)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1834

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

49

i10-index

449

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
96%
ORCID iDs in current deposits
31%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity4
Alternate titles
Official journal of DIATherapeutic innovation and regulatory scienceTIRS
Source type
journal
NLM unique ID (PubMed)
101597411
Society affiliations
Drug Information Association
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Statistical Methods in Clinical Trials
  • Statistical Methods in Clinical Trials
  • Pharmaceutical Economics and Policy
  • Pharmaceutical Economics and Policy
  • Biomedical Ethics and Regulation
  • Biomedical Ethics and Regulation
Show all subjects (50)
  • Ethics in Clinical Research
  • Ethics in Clinical Research
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
  • Pharmaceutical industry and healthcare
  • Pharmaceutical industry and healthcare
  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmacovigilance and Adverse Drug Reactions
  • Biosimilars and Bioanalytical Methods
  • Biosimilars and Bioanalytical Methods
  • Meta-analysis and systematic reviews
  • Meta-analysis and systematic reviews
  • Advanced Causal Inference Techniques
  • Pharmaceutical Quality and Counterfeiting
  • Advanced Causal Inference Techniques
  • Pharmaceutical Quality and Counterfeiting
  • Mental Health and Patient Involvement
  • Mental Health and Patient Involvement
  • Health and Medical Research Impacts
  • Electronic Health Records Systems
  • Health and Medical Research Impacts
  • Electronic Health Records Systems
  • Biotechnology and Related Fields
  • Biotechnology and Related Fields
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Economic and Financial Impacts of Cancer
  • Economic and Financial Impacts of Cancer
  • Health Literacy and Information Accessibility
  • Health Literacy and Information Accessibility
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmacy and Medical Practices
  • Pharmacy and Medical Practices
  • Optimal Experimental Design Methods
  • Optimal Experimental Design Methods
  • Medication Adherence and Compliance
  • Medication Adherence and Compliance
  • Mobile Health and mHealth Applications
  • Mobile Health and mHealth Applications
  • Health Policy Implementation Science
  • Health Policy Implementation Science

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: